ODI Pharma AB (publ) (NGM: ODI)

ODI Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	78	110	84	82	68	85
Market Cap Growth	30.91%	30.91%	1.85%	21.08%	-20.36%	-
Enterprise Value	76	104	80	73	52	63
Last Close Price	5.15	7.20	5.50	5.40	4.46	5.60
PE Ratio	220.20	307.85	-12.22	-11.25	-17.15	-15.56
PS Ratio	3.49	4.88	600.26	262.63	-	-
PB Ratio	35.35	49.42	32.54	8.87	4.16	4.25
P/FCF Ratio	-30.13	-30.13	-16.40	-11.14	-11.20	-17.86
P/OCF Ratio	-30.13	-30.13	-16.40	-11.15	-11.20	-17.96
EV/Sales Ratio	3.37	4.62	573.75	233.92	-	-
EV/EBITDA Ratio	61.97	84.80	-11.75	-10.17	-13.16	-12.77
EV/EBIT Ratio	62.12	85.01	-11.75	-10.16	-13.14	-12.74
EV/FCF Ratio	-28.50	-28.50	-15.68	-9.92	-8.59	-13.17
Asset Turnover	2.19	2.19	0.01	0.02	-	-
Inventory Turnover	-	-	0.77	0.34	-	-
Quick Ratio	1.17	1.17	1.30	6.84	26.74	26.33
Current Ratio	1.22	1.22	1.46	8.49	29.00	26.53
Return on Equity (ROE)	14.86%	14.86%	-116.63%	-56.64%	-21.89%	-41.15%
Return on Assets (ROA)	7.45%	7.45%	-45.57%	-32.91%	-13.13%	-24.35%
Return on Capital (ROIC)	31.82%	31.82%	-71.95%	-35.25%	-13.62%	-25.57%
Earnings Yield	0.45%	0.32%	-8.24%	-8.81%	-5.87%	-5.82%
FCF Yield	-3.32%	-3.32%	-6.10%	-8.98%	-8.93%	-5.60%
Buyback Yield / Dilution	0.76%	0.76%	-1.69%	1.52%	-11.10%	-10.04%
Total Shareholder Return	0.76%	0.76%	-1.69%	1.52%	-11.10%	-10.04%

Source: S&P Capital IQ. Standard template. Financial Sources.